Pre-diagnostic blood biomarkers for adult glioma

Lily Andrews*, Philippa Davies, Christopher C Herbert, Kathreena M Kurian

*Corresponding author for this work

Research output: Contribution to journalReview article (Academic Journal)peer-review

5 Citations (Scopus)
38 Downloads (Pure)


Glioma is one of the most common malignant primary brain tumours in adults, of which, glioblastoma is the most prevalent and malignant entity. Glioma is often diagnosed at a later stage of disease progression, which means it is associated with significant mortality and morbidity. Therefore, there is a need for earlier diagnosis of these tumours, which would require sensitive and specific biomarkers. These biomarkers could better predict glioma onset to improve diagnosis and therapeutic options for patients. While liquid biopsies could provide a cheap and non-invasive test to improve the earlier detection of glioma, there is little known on pre-diagnostic biomarkers which predate disease detection. In this review, we examine the evidence in the literature for pre-diagnostic biomarkers in glioma, including metabolomics and proteomics. We also consider the limitations of these approaches and future research directions of pre-diagnostic biomarkers for glioma.
Original languageEnglish
Article number1163289
Number of pages10
JournalFrontiers in Oncology
Publication statusPublished - 17 May 2023

Bibliographical note

Funding Information:
LA and KK is funded by Cancer Research UK [grant number C30758/A29791]. KK is funded by Innovate [grant number 10027624]. This work was supported by Cancer Research UK [grant number C18281/A29019 and C18281/A30905].

Publisher Copyright:
Copyright © 2023 Andrews, Davies, Herbert and Kurian.

Structured keywords

  • ICEP


Dive into the research topics of 'Pre-diagnostic blood biomarkers for adult glioma'. Together they form a unique fingerprint.

Cite this